SECOR Capital Advisors, LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 82 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
SECOR Capital Advisors, LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$627,000
-19.7%
66,944
+10.1%
0.08%
-3.5%
Q1 2017$781,000
+25.0%
60,804
-8.5%
0.08%
+11.8%
Q4 2016$625,00066,4840.08%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders